tradingkey.logo

West Pharmaceutical Services Inc

WST
View Detailed Chart
272.440USD
+3.780+1.41%
Close 12/19, 16:00ETQuotes delayed by 15 min
19.59BMarket Cap
40.12P/E TTM

West Pharmaceutical Services Inc

272.440
+3.780+1.41%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.41%

5 Days

+1.82%

1 Month

+5.69%

6 Months

+26.23%

Year to Date

-16.83%

1 Year

-17.79%

View Detailed Chart

Key Insights

West Pharmaceutical Services Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 28/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 345.24.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

West Pharmaceutical Services Inc's Score

Industry at a Glance

Industry Ranking
28 / 208
Overall Ranking
97 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 18 analysts
Buy
Current Rating
345.245
Target Price
+28.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

West Pharmaceutical Services Inc Highlights

StrengthsRisks
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.08%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.08%.
Fairly Valued
The company’s latest PE is 40.14, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 70.77M shares, decreasing 3.20% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 816.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.15.

West Pharmaceutical Services Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

West Pharmaceutical Services Inc Info

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Ticker SymbolWST
CompanyWest Pharmaceutical Services Inc
CEOGreen (Eric Mark)
Websitehttps://www.westpharma.com/

FAQs

What is the current price of West Pharmaceutical Services Inc (WST)?

The current price of West Pharmaceutical Services Inc (WST) is 272.440.

What is the symbol of West Pharmaceutical Services Inc?

The ticker symbol of West Pharmaceutical Services Inc is WST.

What is the 52-week high of West Pharmaceutical Services Inc?

The 52-week high of West Pharmaceutical Services Inc is 348.900.

What is the 52-week low of West Pharmaceutical Services Inc?

The 52-week low of West Pharmaceutical Services Inc is 187.430.

What is the market capitalization of West Pharmaceutical Services Inc?

The market capitalization of West Pharmaceutical Services Inc is 19.59B.

What is the net income of West Pharmaceutical Services Inc?

The net income of West Pharmaceutical Services Inc is 492.70M.

Is West Pharmaceutical Services Inc (WST) currently rated as Buy, Hold, or Sell?

According to analysts, West Pharmaceutical Services Inc (WST) has an overall rating of Buy, with a price target of 345.245.

What is the Earnings Per Share (EPS TTM) of West Pharmaceutical Services Inc (WST)?

The Earnings Per Share (EPS TTM) of West Pharmaceutical Services Inc (WST) is 6.790.
KeyAI